oncology pipeline – Discover Pharma

Welcome to Discover Pharma! Today is : October 22, 2026

oncology pipeline

Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Research & Development
Thalia Therapeutics acquires Sanmirna and raises £2.75M to advance AML RNA therapy
Thalia Therapeutics has agreed a Sanmirna acquisition and £2.75m fundraise [...]

June 25, 2026
Biotech & Pharma Business,Drug Discovery & Development,Pharmaceuticals and therapeutics
InduPro licenses Lonza ADC technology for oncology programmes
InduPro has licensed Lonza’s antibody-drug conjugate technologies to support development [...]

June 22, 2026
Clinical & Regulatory,Therapeutic Areas
Kainova Therapeutics doses first patient in Europe in phase 1/2 anti-CCR8 antibody trial
Kainova Therapeutics has dosed the first patient in Europe in [...]

May 5, 2026
Biotech & Pharma Business,Pharmaceuticals and therapeutics,Therapeutic Areas
Kainova Therapeutics raises $32m CAD Series B to advance immuno-oncology and inflammation pipeline
Kainova Therapeutics has secured $32m CAD in a Series B [...]

May 5, 2026
Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas
Amorphical names Eden Ben CEO to drive regulatory strategy and expand nano-mineral therapeutics pipeline
Amorphical has appointed Eden Ben as chief executive officer, as [...]

May 5, 2026

main menu

recent posts

get connected

This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.

OK